The Food and Drug Administration has revealed that the maker of a brand of eye drops linked to an outbreak of fatal bacterial infections failed to follow multiple safety protocols.
The FDA visited a Global Pharma Healthcare facility in India for an inspection in mid-February and found dozens of issues ranging from dirty equipment and clothing to missing safeguards and procedures.
The inspection came two-and-a-half weeks after the company voluntarily recalled the EzriCare artificial tears product because of possible contamination.
When the recall was issued, there were already 55 reports of adverse events, including eye infections, permanent loss of vision, and at least one death from a bloodstream infection.
California regulators have revoked the license of a robotaxi service owned by General Motors after determining its driverless cars that recently began transporting passengers throughout San Francisco are a dangerous menace.
Walmart, the nation's largest private employer, is expanding nationwide its health care coverage next month for employees who want to enlist the services of a doula, a person trained to assist women during pregnancies.
A group of 33 states including California and New York are suing Meta Platforms Inc. for harming young people’s mental health and contributing the youth mental health crisis by knowingly designing features on Instagram and Facebook that addict children to its platforms.
